Sumitomo Mitsui Trust Group
JAZZ icon

Sumitomo Mitsui Trust Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Buy
6,770
+170
+3% +$37.2K ﹤0.01% 830
2026
Q1 		$1.25M Buy
6,600
+3,000
+83% +$524K ﹤0.01% 837
2025
Q4 		$612K Buy
+3,600
New +$552K ﹤0.01% 916
2024
Q3 		– Sell
-18,119
Closed -$1.93M – 1076
2024
Q2 		$1.93M Sell
18,119
-141,198
-89% -$15.5M ﹤0.01% 838
2024
Q1 		$19.2M Sell
159,317
-3,117
-2% -$382K 0.01% 716
2023
Q4 		$20M Sell
162,434
-1,177
-0.7% -$147K 0.01% 704
2023
Q3 		$21.2M Sell
163,611
-845
-0.5% -$113K 0.02% 687
2023
Q2 		$20.4M Sell
164,456
-9,807
-6% -$1.32M 0.02% 704
2023
Q1 		$25.5M Sell
174,263
-2,125
-1% -$314K 0.02% 677
2022
Q4 		$28.1M Buy
176,388
+521
+0.3% +$76.4K 0.02% 647
2022
Q3 		$23.4M Buy
175,867
+126
+0.1% +$19.2K 0.02% 679
2022
Q2 		$27.4M Sell
175,741
-5,424
-3% -$835K 0.02% 673
2022
Q1 		$28.2M Buy
+181,165
New +$26.3M 0.02% 668

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Sumitomo Mitsui Trust Group's JAZZ Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group increased its Jazz Pharmaceuticals (JAZZ) stake by 2.6% in Q2 2026, buying an estimated $37.2K and bringing the position to 6,770 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #830.

Sumitomo Mitsui Trust Group first reported a position in JAZZ in Q1 2022 and has held it in 13 quarters since. The position peaked at $28.2M in Q1 2022. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 6,770 shares of Jazz Pharmaceuticals worth $1.63M as of Q2 2026.
  • Sumitomo Mitsui Trust Group bought 170 Jazz Pharmaceuticals shares in Q2 2026, an estimated $37.2K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #830 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Jazz Pharmaceuticals in Q1 2022 and has held it in 13 quarters since.
  • Sumitomo Mitsui Trust Group's Jazz Pharmaceuticals position peaked at $28.2M in Q1 2022.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.